Y. Imazono et al., CORRELATION BETWEEN THYMIDINE PHOSPHORYLASE EXPRESSION AND PROGNOSIS IN HUMAN RENAL-CELL CARCINOMA, Journal of clinical oncology, 15(7), 1997, pp. 2570-2578
Purpose: Thymidine phosphorylase (TP) is identical to platelet-derived
endothelial cell growth factor (PD-ECGF) and has angiogenic activity.
We examined whether TP expression in renal cell carcinoma (RCC) is as
sociated with microvessel density as a marker of angiogenesis, clinico
pathologic characteristics, and outcome, Patients and Methods: The enz
ymatic activity and expression of TP were examined in 18 RCCs and 19 k
idney tissues not grossly involved with tumor from 24 patients with 13
paired samples and 11 unpaired samples by spectrophotometry and immun
oblotting, The relationship between TP expression and microvessel dens
ity was assessed by immunohistochemistry in 133 RCCs, Results: The med
ian enzymatic activity of TP in RCCs was nine fold higher than that in
nonneoplastic kidney tissues (P < .001), Similar results were obtaine
d by immunoblot analysis. According to the TP staining profile, tumors
were classified as no or low, intermediate, or high TP-expressing tum
ors, TP positivity was significantly correlated with microvessel densi
ty, TP expression was correlated with tumor grade, but there was no si
gnificant association between TP expression and other clinicopathologi
c characteristics. TP expression as a prognostic variable was studied
using Cox's proportional hazards model, TP overexpression was on indep
endent prognostic factor (hazards ratio, 3.95; 95% confidence interval
, 0.98 to 15.89; P = .039) as were nodal category, metastases category
, tumor grade, and venous invasion. Conclusion: These findings suggest
that TP expression is correlated with microvessel density in RCC and
is an unfavorable independent prognostic factor. The future developmen
t and characterization of TP inhibitors may provide a novel approach t
o the therapy of RCC. (C) 1997 by American Society of Clinical Oncolog
y.